
Excelsior Sciences accelerates discovery and scale-up of small-molecule compounds by combining machine-executable chemistry with AI-guided design. It uses a proprietary "smart bloccs" system of modular, automation-ready chemical building blocks that act as tokens in a modular chemistry language to enable iterative, closed-loop cycles of AI-directed synthesis, testing, and optimization. The platform integrates automated synthesis hardware, lab automation workflows, and machine-learning models to convert early-stage discovery into manufacturing-ready processes. Excelsior serves pharmaceutical and materials customers, maintains an internal therapeutic pipeline, and partners with organizations to deploy its platform across industries that rely on small molecules.

Excelsior Sciences accelerates discovery and scale-up of small-molecule compounds by combining machine-executable chemistry with AI-guided design. It uses a proprietary "smart bloccs" system of modular, automation-ready chemical building blocks that act as tokens in a modular chemistry language to enable iterative, closed-loop cycles of AI-directed synthesis, testing, and optimization. The platform integrates automated synthesis hardware, lab automation workflows, and machine-learning models to convert early-stage discovery into manufacturing-ready processes. Excelsior serves pharmaceutical and materials customers, maintains an internal therapeutic pipeline, and partners with organizations to deploy its platform across industries that rely on small molecules.